申请人:Guangzhou Ribobio Co., Ltd.
公开号:EP3677588A1
公开(公告)日:2020-07-08
The present invention falls within the field of biomedical technology, and in particular relates to modified oligonucleotides and a compound that can be used for synthesizing same and a method for modifying oligonucleotides. The present invention also relates to the use of the modified oligonucleotides for preventing and/or treating diseases associated with the liver in a subject.
本发明属于生物医学技术领域,尤其涉及修饰的寡核苷酸和可用于合成修饰的寡核苷酸的化合物以及修饰寡核苷酸的方法。本发明还涉及使用经修饰的寡核苷酸预防和/或治疗受试者与肝脏有关的疾病。